ABIVAX Société Anonyme (EPA:ABVX)
France
· Delayed Price · Currency is EUR 5.64
-0.53 (-8.59%)
May 12, 2025, 5:35 PM CET
ABIVAX Société Anonyme Revenue
In the year 2024, ABIVAX Société Anonyme had annual revenue of 10.79M EUR with 135.94% growth. ABIVAX Société Anonyme had revenue of 4.01M in the half year ending December 31, 2024, with 78.20% growth.
Revenue
10.79M
Revenue Growth
+135.94%
P/S Ratio
33.15
Revenue / Employee
156.41K
Employees
69
Market Cap
357.72M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 10.79M | 6.22M | 135.94% |
| Dec 31, 2023 | 4.57M | 69.00K | 1.53% |
| Dec 31, 2022 | 4.51M | 302.00K | 7.19% |
| Dec 31, 2021 | 4.20M | 4.19M | 29,921.43% |
| Dec 31, 2020 | 14.00K | 21.00K | -300.00% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sanofi | 45.17B |
| EssilorLuxottica Société anonyme | 26.51B |
| Sartorius Stedim Biotech | 2.86B |
| bioMérieux | 3.98B |
| Eurofins Scientific SE | 6.95B |
| Ipsen | 3.57B |
| Virbac | 1.40B |
| emeis Société anonyme | 5.64B |
ABIVAX Société Anonyme News
- 13 days ago - Abivax Announces Completion of Enrollment for the Phase 3 ABTECT Trials in Patients with Moderately to Severely Active Ulcerative Colitis - GlobeNewsWire
- 20 days ago - Abivax Announces Annual General Meeting Details as Company Advances Toward Key 2025 Value-Driving Milestones - GlobeNewsWire
- 20 days ago - Abivax Announces Appointment of Dominik Höchli, MD to Board of Directors - GlobeNewsWire
- 6 weeks ago - ABIVAX: Undercovered, Late-Stage French Company With Upcoming Catalysts - Seeking Alpha
- 6 weeks ago - Abivax publishes financial reports with the French and U.S. securities regulatory agencies - GlobeNewsWire
- 7 weeks ago - Abivax reports FY results - Seeking Alpha
- 7 weeks ago - Abivax Announces Full Year 2024 Financial Results - GlobeNewsWire
- 2 months ago - Abivax to Host Key Opinion Leader (KOL) Webcast on March 17, 2025 - GlobeNewsWire